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Rites of passage
Graduates celebrated at recognition  
and hooding events across the School  
of Medicine at Washington University’s 
151st Commencement held on May 18. 
Ceremonies recognized medical students, 
graduates of the school’s 
programs in Occupational 
Therapy, Physical Therapy 
and Audiology and Communication 
Sciences, and doctoral graduates from 
the Division of Biology and Biomedical 
Sciences. At left, former students prepare 
to join their families and friends following 
Commencement at America’s Center in 
downtown St. Louis.
View enhanced content online:  
outlook.wustl.edu   
Like the School of Medicine on Facebook:  
facebook.com/WUSTLmedicine.health   
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The bacterium Enterococcus faecalis, which lives in 
the human gut, is just one type of microbe studied as 
part of the Human Microbiome Project funded by the 






















rillions of microbes inhabit the 
human body, occupying virtually 
every nook and cranny. And most 
of the time, this relationship is a friendly 
one, with microbes helping to digest food, 
strengthen the immune system and ward 
off dangerous pathogens. 
But despite microbes’ prominent roles, 
researchers have understood little about 
which of them reside in specific sites of  
the body. Now, a consortium of some  
200 U.S. scientists reports findings from  
the most comprehensive census of the 
microbial makeup of healthy humans. 
The research, published June 14, 2012, 
in Nature and in several Public Library of 
Science (PLoS) journals, offers new details 
and even some surprises.
For example, the researchers found that 
even healthy people typically carry low 
levels of harmful bacteria in and on their 
bodies. But when a person is healthy, these 
pathogens don’t cause disease; they sim-
ply coexist in an abundance of beneficial 
microbes. Now, scientists can investigate 
why some pathogens suddenly turn deadly, 
which will refine current thinking on how 
microorganisms cause disease. 
“It’s not possible to understand human 
health and disease without exploring the 
massive community of microorganisms 
we carry around with us,” says George M. 
Weinstock, PhD, associate director of The 
Genome Institute at Washington University 
and one of the project’s principal investiga-
tors. “Knowing which microbes live in various 
ecological niches in healthy people allows 
us to better investigate what goes awry in 
diseases that are thought to have a micro-
bial link, like Crohn’s and obesity, and why 
dangerous pathogens sometimes, but not 
always, cause life-threatening illnesses.”
Washington University and its Genome 
Institute played a major role in the research, 
known as the Human Microbiome Project. 
The five-year initiative was funded with  
$153 million from the National Institutes of 
Health (NIH), with some $32 million coming 
to Washington University.
Genome Institute scientists decoded 
about half of the 5,000 specimens from 
nearly 250 healthy volunteers. 
 “Data generated from this study has the 
added potential to provide scientists with 
new insights into how local environments 
shape the composition of microbes that are 
found in healthy individuals,” says co-inves-
tigator Mark A. Watson, MD, PhD, associate 
professor of pathology and immunology.
Viruses, bacteria and fungi abound in healthy people
Microbial zoo
Scientists identified  
more than 10,000 species 
of microbes that occupy 
the human ecosystem, 
documenting the impressive 
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Jerey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished 
University Professor and director of Washington University’s 
Center for Genome Sciences and Systems Biology, will lead 
an international team of scientists to nd new ways to diag-
nose, treat and prevent a critical global health problem: mal-
nutrition in infants and children. e work is funded by an 
$8.3 million grant from the Bill & Melinda Gates Foundation.
Gordon’s research rst established a link between obesity 
and the trillions of friendly microbes that live in the intes-
tine, where they extract nutrients and calories from food. 
His studies have shown that diet helps shape the mix of 
microbes in the intestine and that these microbes, in turn, 
inuence how eciently nutrients and calories are harvested 
from foods. is dynamic interplay has led Gordon to sus-
pect that an imbalance of certain types of gut microbes  
conspires with an inadequate diet to trigger malnutrition.
“A complex relationship exists between diet, gut  
microbial communities and the immune system in severely 
malnourished children,” says Gordon. “We now have a  
way to tease apart these inuences. is project seeks to  
discover novel dietary and microbial therapeutics that can  
be targeted to infants and children living in countries with 
rampant malnutrition.”
Severe malnutrition  
has long been thought to 
stem simply from a lack of 
adequate food. But now  
scientists understand the 
condition is far more com-
plex and may involve a 
breakdown in the way gut 
microbes process various 
components of the diet.
e community of intestinal microbes and their vast  
collection of genes, known as the gut microbiome, are 
assembled right from birth and inuenced by babies’ early 
environments and the rst foods they consume, such as 
breast milk. As part of the Breast Milk, Gut Microbiome and 
Immunity Project, Gordon will work with other scientists to 
evaluate the relationship among rst foods, the developing 
community of microbes in the intestine and the developing 
immune system.
Gordon’s research underscores the need to understand the 
workings of gut microbiomes among people of dierent ages 
living in dierent parts of the world, especially as scientists 
consider manipulating intestinal microbes to improve health 
and nutrition. 
Summer school   Lawrence M. Lewis, MD, professor of 
emergency medicine, studies a sonogram in the emergency room 
with Amanda Fletcher, a student from Meharry Medical College. 
Fletcher and 10 other Meharry students visited Washington University 
School of Medicine over the summer to participate in a program  
coordinated by the Office of Medical Student Research. Each student 
is paired with a faculty mentor and given the opportunity to conduct 
research. Fletcher is studying whether higher health literacy  
correlates with better self-management of hypertension. As part  
of her experience, she is shadowing Lewis in the emergency room  








Pediatric quintet tapped as leaders
Washington University’s Department of Pediatrics and  
St. Louis Children’s Hospital once again have been catapulted 
into the national spotlight — this time by the simultaneous 
election of ve pediatric faculty into the 
top national leadership roles in large 
and distinguished medical societies.
omas W. Ferkol Jr., MD, was 
installed as vice president of the 
American oracic Society. Keith A. 
Hruska, MD, was elected president of 
the American Society for Bone and 
Mineral Research. David M. Jae, 
MD, was installed as president of the 
Academic Pediatric Association. Alan 
L. Schwartz, PhD, MD, will become 
president of the American Pediatric 
Society. Gregory A. Storch, MD, is 
president-elect of the Pan American 
Society for Clinical Virology. 
“Election to lead a major academic society is a mark 
of distinction,” says Schwartz, the Harriet B. Spoehrer 
Professor and head of the Department of Pediatrics. “We are 
very proud of the recognition of Drs. Ferkol, Hruska, Jae 
and Storch by their peers nationally. is is a most unusual 
concurrence, and one that highlights Washington University 
School of Medicine.”
 
The new research builds  
on ongoing clinical studies  
in Africa, South Asia  
and South America of  
malnourished and healthy 
infants and children and 
their mothers.
Global team of scientists to 
study childhood malnutrition
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Researchers at the School of Medicine have received a  
$4.7 million grant from the National Heart, Lung, and Blood 
Institute to investigate heart disease in patients with diabetes.
“Diabetes is an incredibly common problem,” says Jean E. 
Schaer, MD, the Virginia Minnich Distinguished Professor 
of Medicine. “It aects a huge swath of the population. 
Importantly, people with diabetes don’t just have a metabolic 
disorder. ey develop complications in many organs. And 
one of the most deadly complications is heart disease. We’re 
particularly interested in why people with diabetes suer 
from unusually severe forms of heart disease.”
For reasons not fully understood, people with diabetes 
are more likely to develop blockages in arteries. Aer a heart 
attack, the course of the sub-
sequent heart disease is more 
aggressive than in people with-
out diabetes. Even independent 
of blocked arteries, there is  
evidence that their hearts do  
not function like those of  
individuals without diabetes.
According to the Centers for 
Disease Control and Prevention, 
almost 26 million Americans 
are living with type 2 diabetes  
and another 79 million with 
undiagnosed diabetes or  
pre-diabetes, a condition that increases their risk of develop-
ing the full-blown variety. With such statistics, it is becom-
ing increasingly important to explore the reasons behind 
the aggressive progress of cardiovascular disease in patients 
whose bodies do not properly regulate blood sugar.
Schaer and her colleagues suspect a likely culprit is 
abnormal lipid metabolism. Lipids are a class of molecules 
that includes fats, such as fatty acids and triglycerides. Past 
studies have shown that patients with diabetes store higher 
levels of these lipids in their heart muscle, likely impairing 
cardiac function. ese lipids appear to lead to inammation 
and can also damage important parts of heart cells, such as 
proteins and DNA, leading to heart muscle dysfunction. e 
goal of the new research program is to identify better mea-
sures of heart disease in patients with diabetes.
Washington University will serve as the coordinating 
center among ve institutions chosen to receive this funding 
from the National Institutes of Health (NIH). e other par-
ticipating centers are the Cleveland Clinic, Emory University, 









Examining the link between  
diabetes and heart disease
Grant to fund collaborative research
Ralph G. Dacey Jr., MD
Enjoy interactive elements and added content
 Ralph G. Dacey Jr., MD, the Henry G. and Edith R. Schwartz 
Professor and head of the Department of Neurosurgery, is 
now president of the Society of Neurological Surgeons (SNS).
e SNS is the American society of leaders in neurosur-
gical residency education and is the oldest neurosurgical 
society in the world. Dacey, who is neurosurgeon in chief at 
Barnes-Jewish Hospital, joins an exclusive group of neuro-
surgical leaders that includes Harvey 
W. Cushing, MD, who is regarded  
as the father of modern neuro- 
surgery and served as the SNS’s rst 
president in 1920. Additionally, each 
of Dacey’s predecessors as head of 
the Department of Neurosurgery 
served terms as president of the SNS: 
Ernest Sachs, MD, the rst professor  
of neurological surgery in the 
world and founding director of the 
Department of Neurological Surgery 
at the School of Medicine; Henry G. 
Schwartz, MD; and Sidney Goldring, 
MD. Sachs was a founding member of the society in 1920.
e group’s goals include promoting improvements 
in education and training for neurosurgical students and 
postgraduates; recognizing outstanding neurosurgical care, 
instruction and research; and encouraging the highest  
standards of care for patients with neurological diseases.
Dacey plans to work with the Accreditation Council for 
Graduate Medical Education to optimize a new set of proce-
dures for accrediting neurosurgical training programs and 
to establish a web portal to help meet the educational needs 
of neurosurgeons at every point in their careers, from  
neurosurgical residents to practicing neurosurgeons.
Dacey heads neurosurgery society
Heavy lifting    
Workers prepare to place a 
new MRI scanner into the 
East Building at Washington 
University School of 
Medicine. The 18,000-pound 
scanner, delivered in June, is 
customized for use in the Human 
Connectome Project, a research study 
that will trace the anatomical and functional 
connections between different regions of the human brain. David C. 
Van Essen, PhD, the Edison Professor and head of the Department of 
Anatomy and Neurobiology, is co-investigator of the project, which 
began scanning brains of research participants in August. The project 
aims to compile unparalleled neural data and to create an interface  
to graphically navigate this information.
“Diabetes is an incredibly 
common problem that 
affects a huge swath of 
the population. We’re 
particularly interested in 
why people with diabetes 
suffer from unusually severe 
forms of heart disease.”  
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hat happens the day before 
a colonoscopy may be just as 
important as the test itself.
Gastroenterologists at the School of 
Medicine have found that when patients don’t 
adequately prep for the test by cleansing their 
colons, doctors often can’t see potentially 
dangerous pre-cancerous lesions.
Reporting in the journal Gastrointestinal 
Endoscopy, the researchers say that doctors 
often missed at least one pre-cancerous 
growth in about one-third of patients who  
did not properly prepare for their colonoscopy. 
Polyps and other markers of cancer risk were 
then discovered in subsequent colonoscopies.
Although several studies have found that 
up to a quarter of colonoscopy patients don’t 
prepare adequately for the test, the new 
study is the first to point out the potential 
consequences of poor bowel preparation in 
outpatients at average risk.
“Because so many of the patients had a 
follow-up screening less than a year after the 
initial test, we strongly suspect that most of 
the pre-cancerous growths found during the 
Poor colonscopy prep hides polyps
W








second colonoscopy already were present at 
the time of the initial test,” says first author 
Reena Chokshi, MD, a gastroenterology fellow 
at Washington University. 
Researchers say their findings suggest that 
if a physician is having difficulty seeing the 
colon due to inadequate bowel prep, the colo-
noscopy should be stopped and rescheduled.
“Rather than subjecting a patient to the 
potential risks of a full colonoscopy when we 
may not be able to detect polyps, or other 
pre-cancerous growths called adenomas, it 
may be better to bring that patient back as 
soon as possible for a repeat procedure with 
better bowel preparation,” says Chokshi.
On the day before a colonoscopy exam, 
people are asked to stop eating solid food and 
to consume only clear liquids. Later in the day 
and the next morning, patients drink bowel-
cleansing mixtures to empty the colon prior 
to the examination.
The test itself usually takes less than an 
hour, and patients are sedated during that 
time. Using a tiny camera, doctors are able to 
look at the walls of the colon in an attempt 
to detect polyps and other pre-cancerous 
growths. Once detected, those growths can 
be removed during the procedure. 
“It generally takes several years for an 
adenoma to become cancerous,” Chokshi says. 
“So it certainly is possible that any lesion we 
miss during a colonoscopy could develop into 
a malignancy before a person’s next colon-


















Global health   Henish A. 
Bhansali, MD, instructor in medicine, 
Victor G. Davila-Roman, MD, professor 
of medicine, and Yeshey Penjore, MD, a 
cardiologist from the National Referral 
Hospital in Thimpu, Bhutan, review a 
heart echocardiogram. Penjore trained 
at the School of Medicine for two months 
as part of the Global Health Scholars 
in Medicine Program, a Department of 
Medicine initiative designed to expand 
global health education. Penjore also 
attended continuing medical education 
courses and worked alongside Washington 
University cardiologists, experiences he 
will use to better diagnose and treat his 
patients in Bhutan, where there is a high 
prevalence of congenital heart disease.
Doctors discover a polyp during a repeat colonoscopy 
conducted on a study patient who had not prepared 
adequately for the initial exam.
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To speed progress against cancer and other diseases, the  
St. Jude Children’s Research Hospital-Washington University 
Pediatric Cancer Genome Project has announced the largest 
release to date of comprehensive human cancer genome data 
for free access by the global scientic community. 
e amount of information released more than doubles 
the volume of high-coverage, whole-genome data currently 
available from all human genome sources combined. is 
information is valuable not just to cancer researchers, but 
also to scientists studying almost any disease.
e release of this data was announced as a part of a  
perspective published online May 29 in Nature Genetics.
e 520 genome sequences 
released are matched sets 
of normal and tumor tissue 
samples from 260 pediatric can-
cer patients. e St. Jude and 
Washington University research-
ers are analyzing the genomic 
sequences to determine the dif-
ferences between each child’s 
normal and cancerous cells to 
pinpoint the causes of more than 
a half-dozen of the most deadly 
childhood cancers, an eort 
which has already produced 
a number of key discoveries 
reported in top scientic journals.
Launched in early 2010, the Pediatric Cancer Genome 
Project is the world’s largest eort and investment to date  
to understand the genetic origins of childhood cancers.  
e three-year project will cost an estimated $65 million.  
St. Jude is covering $55 million of the cost, including a $20 
million commitment from Kay Jewelers, a long-standing 
partner of St. Jude. is is the rst major privately funded 
human genome sequencing project to share its data as soon 
as it becomes available.
“is approach has been more valuable than anyone could 
have predicted,” says Richard K. Wilson, PhD, director of 
e Genome Institute. “We have identied unusual, ‘cryptic’ 
changes in many patients’ cancer cells that we would not 
have found using other methods. We are pleased to be able 
to share this data with the research community in hopes  
that others can build upon our initial discoveries.”
Largest-ever share of cancer 
genome data released










 With more than $5 million in new grants from Susan G. 
Komen for the Cure, Washington University scientists at the 
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and 
Washington University School of Medicine are developing 
innovative treatments in the ght against breast cancer.
e largest portion — $4 million — will be used to bet-
ter identify which women with estrogen receptor-positive 
(ER-positive) breast cancer, the most common form of the 
disease, are at highest risk for recurrence and to determine 
more eective treatments for those individuals.
“ere are so many new drugs out there for breast cancer 
patients that we need a way to establish which ones are most 
likely to be the home run,” says 
Matthew J. Ellis, MD, PhD, professor 
of medicine and chief of the breast 
oncology section. “Our goal is to 
screen drugs to nd the one that  
will produce the best outcome for 
the patient with the least toxicity.”
Ellis is a co-recipient of the 
grant along with Elaine R. Mardis, 
PhD, co-director of e Genome Institute at the School of 
Medicine, and Pascal Meier, PhD, of e Institute of Cancer 
Research in London.
Using DNA sequencing to compare a patient’s normal 
and cancerous cells, the researchers are learning why tradi-
tional anti-hormone drugs oen are only partially eective 
in reducing tumor growth. e study involves developing a 
test to predict which patients are most likely to experience 
recurrence aer ve years and determining which combina-
tion of drugs now in development will kill all ER-positive 
cancer cells and prevent recurrence.
Siteman welcomes Komen funding
 
A new test under develop-
ment will predict breast 
cancer recurrence and  
also protect women from 
unnecessary treatment  
and follow-up visits.
Research rewarded   Morton E. Smith, MD, councilor 
for the Washington University chapter of Alpha Omega Alpha (AOA), 
congratulates first-year medical student Gregory C. Ebersole, the 2012 
recipient of the AOA’s Carolyn L. Kuckein Student Research Fellowship. 
Ebersole is studying the responsiveness and validity of a postsurgical 
functional assessment survey for cubital tunnel syndrome, a condition 
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WATERWORLD
Take a look inside a  
splashy research facility
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Infertile eggs are extracted  
using a stereomicroscope.
Zebrafish develop rapidly; at 36 hours, 
an embryo has a complete body with 
most organs and a beating heart. 
Acommon type of minnow, the zebrafish is  increasingly popular in scientific research.
Because its tiny embryos are transparent and 
develop outside the body, zebrafish are useful for 
observing growth and development. In addition, 
while less expensive than mice, research results 
from studying zebrafish have been shown to be 
just as valuable as those from mice.
 Washington University is home to one of  
the largest zebrafish facilities in the world. And 
with robotic feeding and cleaning systems, it is  
the world’s most modern, says Lilianna Solnica-
Krezel, PhD, professor and head of the Department 
of Developmental Biology at the School of Medicine.
“This facility allows us to do large-scale,  
collaborative projects that would not be possible for 
individual investigators.”
The work of more 
than 30 researchers is  
currently supported 
by the facility. Beyond 
sheer numbers of 
fish, other resources 
abound, such as capabili-
ties for obtaining, viewing and manipulating fish 
embryos and calling on the expertise of colleagues 
who can help in evaluating experiments.
Fish larvae beginning their life cycles
Fertilized eggs  
filter through a  
false-bottomed  
mating cage, which 
prevents the fish 
from eating the  
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Systems automate water, 
temperature and more. Each 
room has its own centralized 
life support, including an 
innovative filtration system that passes 
used water through a biological filter 
(below) before reuse. Alarms can alert 
responders to a systems failure.
Large numbers of fish grow quickly as robotic feeding machines  
travel to each tank, providing frequent small meals. 
Fertilized eggs  
filter through a  
false-bottomed  
mating cage, which 
prevents the fish 
from eating the  
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It’s for the kids
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Since its launch in 2006, the Children’s Discovery 
Institute has awarded nearly $29.5 million to researchers 
tackling deadly pediatric diseases ranging from cancer to 
malaria. e targeted eort has united clinicians and inves-
tigators from all corners of Washington University, reaching 
across 16 departments in three schools. 
“In seeking new answers to questions about pediatric  
disease, we need to collaborate and think in bold new ways,”  
says Mary C. Dinauer, MD, PhD, scientic director of the 
Children’s Discovery Institute and professor of pediatrics 
and of pathology and immunology at the School of Medicine. 
Institute-funded projects in four areas — childhood can-
cer, musculoskeletal and metabolic diseases, pulmonary dis-
ease and congenital heart disease — are “discovery research,” 
preliminary studies that may eventually yield new treatments. 
“e Children’s Discovery Institute is an interesting con-
cept developed to fund early-stage research that will lead to 
a better understanding of childhood disease and treatment, 
and in some cases, even prevention,” says Dinauer, who also 
serves as the Fred M. Saigh Distinguished Chair in Pediatric 
Research at St. Louis Children’s Hospital. 
Of the 92 grants awarded to researchers since the 
Institute’s inception, 55 percent were to researchers outside  
the Department of Pediatrics. According to Dinauer, that’s 
unique among children’s disease research. 
“We want these grants to bring people from multiple  
disciplines together to study in this research area,” she says. 
“Other institutions have in-house funding for research, but  
it stays within the department.”
e Children’s Discovery Institute also funds a Faculty 
Scholars Award that provides three years of support to junior 
faculty, allowing them to set up their laboratories, as well  
as a summer research opportunities program for under-
graduate students.
 “In the end, we want to establish new areas of pediatric 
research,” Dinauer says. “Creative collaborations will allow 
us to conduct outstanding investigations that otherwise 
wouldn’t have been possible.”
Advances in pediatric care are no longer enough.  
Today researchers are focused on an even higher goal 
— discovering cures for the most serious disorders of 
childhood. The Children’s Discovery Institute, a joint 
initiative of Washington University School of Medicine 
and St. Louis Children’s Hospital, is designed to change 
the way pediatric research is conducted. 
By funding innovative research and translating discovery 
into treatment, Institute investigators hope to make 
significant advances in caring for sick children.  
B Y  B E T H  M I L L E R
childrensdiscovery.org
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Understanding a silent danger
There is no way to predict 
when a seemingly healthy 
adolescent might experience 
sudden and fatal heart failure. 
A healthy teenager suddenly collapses during soccer practice and dies. Aer his death,  
physicians nd he was harboring a silent killer 
known as hypertrophic cardiomyopathy, a condi-
tion in which the heart muscle becomes thickened, 
making it harder to pump blood out of the heart. 
e condition generally has no symptoms, but 
it is the most common killer of adolescents who 
are otherwise healthy and is the leading reason for 
heart transplants in children.
Despite its preva-
lence, very little is 
known about the genetic 
and molecular makeup 
or the electrical pheno-
types of the hearts of 
children with hypertro-
phic cardiomyopathy. New research funded by the 
Children’s Discovery Institute may change that.
Jeanne M. Nerbonne, PhD, the Alumni 
Endowed Professor of Molecular Biology and 
Pharmacology in Developmental Biology, and 
her colleagues received a large initiative grant 
from the Institute to develop the Translational 
Cardiovascular Tissue Core, a centralized system 
for acquiring, banking, annotating with clinical 
data, and distributing tissue from diseased hearts. 
It is directed by Kathryn A. Yamada, PhD, professor 
of medicine in the Cardiovascular Division.
“As individuals develop heart failure,” says 
Nerbonne, “we do not know how to predict who  
is going to have the fatal sudden death incident.  
It has become increasingly clear that detailed  
electrophysiological and molecular analyses of  
diseased and non-diseased human hearts are 
urgently needed to advance the eld.”
Nerbonne, professor of medicine, and her team 
take tissue samples from the diseased hearts of 
children at the time they get a ventricular-assist 
device, which helps the heart pump blood and 
is oen used as a bridge to a heart transplant. 
Investigators then perform various studies on 
these tissues, looking at the proteins, RNA, cel-
lular and whole tissue physiology, as well as bank 
tissue for genetic and epigenetic analyses. ey 
also collect diseased hearts at the time of trans-
plant and perform similar studies, comparing 
what they nd with non-diseased heart tissue.
Notably, the banked tissue and associated data 
will be available to all Washington University 
investigators for further types of analysis.  
“As the science moves forward,” Nerbonne says, 
“other researchers will be able to take a dierent 
look at the data for new discoveries.”
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The Translational Cardiovascular Tissue Core established by 
Jeanne M. Nerbonne, PhD, and colleagues allows scientists to 



























123225_OL12_10-15_CS5.indd  12 8/16/12  1:05 PM
Outlook  13
Swatting malaria more effectively
Malaria is hard to control 
because the parasite has 
become resistant to current 
anti-malarial drugs.
Internationally, there are 250 million to 350 million cases of malaria each year, resulting in 
about 1 million deaths. Most of those deaths are 
children under age 5.
Audrey R. Odom, MD, PhD, wants to cure 
malaria. e pediatric infectious disease specialist  
has been working toward that goal since she came 
to the School of Medicine in 2008 with a Children’s 
Discovery Institute Faculty Scholars Award. 
Odom’s background in cell signaling in eukary-
otic organisms, or 
microbes that have a 
nucleus and organ-
elles like human cells, 
led her to apply that 
knowledge to a eukary-
otic pathogen in child 
health. An assistant professor of pediatrics and 
of molecular microbiology, Odom says malaria is 
hard to control because the parasite has become 
resistant to nearly all currently available anti-
malarial drugs. 
“Chloroquine, a mainstay drug for nearly  
100 years, is resistant to malaria worldwide,” 
Odom says. “Every time we develop a new drug, 
we’re going to encounter resistance, so we need to 
establish a continual pipeline of new drugs.” 
With funding from a separate grant from the 
Children’s Discovery Institute, Odom has made 
progress with that pipeline. She has identied a 
metabolic pathway that is present in the malaria 
parasite and is required for it to grow, but that is 
not present in humans. 
“In theory, we can create a safe antimalarial 
drug,” she says. “What makes this pathway even 
more exciting is that it’s also present in the myco-
bacteria that cause tuberculosis, and there’s also a 
real need for new drugs for TB.”
Odom and her colleagues are testing new com-
pounds to see if they inhibit the enzyme and kill 
the malaria parasite. Her research team also is 
screening a large number of existing compounds 
to determine if they have any eect.
But that’s not her ultimate goal.
“I want to identify a small molecule inhibitor 
that we can pitch to pharmaceutical companies to 
treat bacterial infections in the United States and 
that they can then give away to treat malaria and 
TB in the developing world,” Odom says.
But the malaria parasite also likely will become 
resistant to that drug, she says, so her strategy is to 
pair it with another compound. 





























New therapies under investigation by Audrey R. Odom, 
MD, PhD, could stem the threat of malaria, spread by 
mosquitoes to millions of children worldwide every year.
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Banking on a store of knowledge 
Brain tumor treatments — 
while effective — can 
cause brain damage and 
other toxic side effects.
Cancer is the leading cause of death by disease     among U.S. children between infancy and  
age 15. Among major childhood cancers, leuke-
mia and brain and other central nervous system 
tumors make up more than half of new cases.
A child with leukemia — a cancer of the  
blood cells — has a 90 percent chance of long- 
term survival. But only two of three children 
with a malignant brain or central nervous system 
tumor will live beyond ve years. 
According to researchers 
Jerey R. Leonard, MD, and 
Joshua B. Rubin, MD, PhD, 
that needs to change. 
Part of the reason  
pediatric brain tumors are 
so deadly is the lack of sam-
ples on which to do research. With funding from 
the Children’s Discovery Institute, Leonard, asso-
ciate professor of neurosurgery and of pediatrics, 
and Rubin, associate professor of pediatrics, of  
neurology and of neurobiology, have developed a  
pediatric brain tumor data bank. It contains tissue 
samples from brain tumors in children they have 
treated, along with individual patient data such as 
age, sex, type of tumor and type of treatment. New 
data is automatically entered into the databank.
Leonard and Rubin implant the brain tumor 
samples into mouse brains. By studying how the 
tumors grow in the mice, they can screen thou-
sands of existing compounds to determine if  
any work to slow the tumor’s growth or eliminate 
the tumor.
Rubin says that current treatments can be eec-
tive, but they also can cause long-term damage to 
children’s brains. “So,” he says, “even when tumors 
are cured, we are still looking for new treatments 
with less toxicity.” 
Data from the tumor bank also is available to 
other researchers to study brain tumors, perform 
genetic screens or test for new drugs. 
“We have a large number of resources here,” 
Leonard says. “We want people around the coun-
try to view Washington University as the place to 
come for pediatric and adult brain tumor research. 
e Children’s Discovery Institute provides a 
unique mechanism to support innovative ideas 
and collaborative eorts among departments and 
across campuses, Rubin says.
“What’s smart about setting it up that way is  
it requires people to come up with a novel, col-
laborative approach to pediatric disease,” he says. 
“at prompts research that might not have  
happened without support from the Institute.”
Researchers Joshua B. Rubin, MD, PhD, and Jeffrey R. 
Leonard, MD, use the data bank they created to study 
treatment of pediatric brain tumors.
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Linking rare and common diseases
Thomas W. Ferkol, MD, and a team of diverse researchers  
from across the university are studying persistent respiratory, 
sinus and ear infections in children.
Though treatable, ear 
infections and other 
respiratory infections have 
a high rate of recurrence.
Painful middle ear infections are among the most common infections seen in toddlers  
and young children. Many children nd relief in  
a course of antibiotics, but others experience 
recurrent ear infections. 
To nd answers to what causes these and other 
pediatric respiratory infections, the Children’s 
Discovery Institute awarded a large initiative grant 
to omas W. Ferkol, MD, the Alexis Hartmann, 
MD, Professor in Pediatrics. Ferkol, also professor 
of cell biology and physiol-
ogy, is a world-renowned 
expert on primary ciliary 
dyskinesia (PCD), a rare, 
inherited lung disease that 
results in chronic infections 
of the respiratory tract. 
He and his team are studying the functional, 
structural and genetic characteristics of cilia dis-
eases in children using a single-celled algae model 
that is structurally identical to a human cilium. 
Ultimately, they will learn more about common 
childhood diseases that could lead to better care, 
prevention and identication of new treatments. 
e cilia are tiny, hair-like structures in the 
lungs, nose, sinuses and ears that help clear out 
mucus, foreign particles, uids and bacteria. 
When the cilia don’t function correctly, children 
develop respiratory, sinus and ear infections. 
In PCD, which occurs in about one in every 
12,000 to 20,000 births, cilia are unable to clear 
out bacteria-lled mucus from the lungs, sinuses 
and ears, resulting in persistent infections. Ferkol 
and the research team suspect a link between com-
mon ear infections and the relatively rare PCD. 
“Children who get chronic ear infections, 
requiring repeated treatment with antibiotics and 
sometimes surgeries, also may have genetic and 
functional defects of the cilia, similar to children 
with PCD, but much less severe,” he says.
e team has found genetic mutations that may 
impact cilia and agella, another hair-like struc-
ture that functions much like cilia. e mutations 
disrupt the biochemical pathways of motor pro-
teins that surround each cilium and make it move. 
“Our goal is to connect specic abnormalities 
of cilia motion with a child’s genetic prole, then 
connect that with a child’s disease,” Ferkol says. 
“One day, we could potentially personalize treat-
ment to the genetics and cilia motion abnormali-
ties present in each child.”
Ferkol says the collaboration and support  
from the Children’s Discovery Institute have been 
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labs integrate bone, muscle  
and connective tissue research     
B Y  J I M  D R Y D E N
Makingonnections
50+Advocating a systems view of musculo-skeletal health: Roberto Civitelli, MD,
and Linda J. Sandell, PhD
ROBERT BOSTON
C
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e focus of bone health has long been repair. 
Broken bones, torn ligaments and damaged carti-
lage either can be put in a cast to heal or surgically 
repaired to restore normal function. Or, a worn 
joint can be totally replaced. But that only xes 
the mechanical breakdown. It doesn’t address the 
underlying problems that led to the breakdown of 
bones, muscles, tendons, ligaments and cartilage.
“If you’re going to have biological solutions,”  
says Linda J. Sandell, PhD, the Mildred B. Simon 
Research Professor of Orthopaedic Surgery and 
professor of cell biology and physiology, “you need 
to reach back from the structure to the things that 
are performing the function.”
“Exactly,” echoes Roberto Civitelli, MD, the 
Sydney M. and Stella H. Schoenberg Professor of 
Medicine and chief of the Division of Bone and 
Mineral Diseases. “We must cover the spectrum, 
from the basic biology to cell biology to the signals 
between cells that regulate breakdown and healing. 
It is much cheaper to prevent problems such as 
fractures than to treat them aer they occur.”
At the new Washington University Center for 
Musculoskeletal Research, researchers are attempt-
ing to do just that. By employing a collaborative 
approach, they hope to better understand the  
biological underpinnings of problems with bones 
and connective tissue.    C O N T I N U E D  O N  P A G E  2 0  »
Makingonnections




Daily stress makes these areas trouble-prone. 
Healthy eating and staying active will  
maintain the skeleton. But in some cases,  
targeted drug therapies may forestall disease, 
prevent fractures and limit the need for costly 
joint replacements.
UNLIKE A PIECE OF CHALK,  bone is no dry, static thing wearing away 
with use. A structure at rest, a 
machine in motion, the living 
skeleton renews itself in cycles, 
regulating and interacting with  
tissues and systems throughout the 
body. Musculoskeletal performance 
peaks in adulthood and then 
declines, a precursor to pain,  
disease and fractures.
At the Musculoskeletal Research 
Center, collaborative teams strive to 
understand the complex foundations 
of bone, joint and muscle health.  
ese ndings will be applied to 
osteoporosis, osteoarthritis and 
other musculoskeletal conditions. 
Earlier detection and treat-
ment — or nding the 
means to avoid disease 
altogether — will help  
to ensure a skeleton’s 
long and active life.  
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Balancing act    
   osteoporosis  
Painful legacy    
   osteoarthritis  
Why doesn’t everyone get 
osteoarthritis (OA)? The disease 
affects skeletal joints and 
cartilage, the “cushion” between 
the bones. Research shows that 
some animals inherit the ability 
to repair damaged cartilage. 
Understanding and possibly 
enhancing this repair process  
in humans is one goal of  
OA research.
A body tears down and rebuilds 
its skeleton every 10 years or so. 
This natural cycle is key to 
skeletal health — that is, as long 
as the resorption and formation 
processes remain balanced. 
Once bone formation slows later 
in adulthood, however, excess 
resorption can weaken bones, 
increasing the risk of fractures. 
Drug therapies that rebalance 
the cycle can mitigate the disease 
known as osteoporosis.
R I S K
Age 50+












Excess resorption  
leads to osteoporosis
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“e skeleton and its components 
are part of the organism,” says Civitelli, 
professor of orthopaedic surgery and 
of cell biology and physiology and the 
leader of an NIH-funded training pro-
gram in skeletal disorders. “Without 
the skeleton, you don’t have any way for 
muscles to function. You would have no 
protection of so tissues, and you would 
have no way of regulating many key  
cellular processes. We’re even learning 
that bone is necessary for normal  
glucose metabolism.” 
“Roberto’s point is that the bone is 
doing more than just taking care of 
itself,” Sandell adds. “We’ve got cells 
that make bone and cells that resorb 
bone, the so-called osteoblasts and 
osteoclasts. ose regulate the bone, 
but the bone appears to be regulating 
other things. ere are clear connec-
tions between diabetes and obesity and inammation and 
the skeleton. at’s why we need all of these investigators 
working together. One specialty just doesn’t bring enough  
to the table to understand this anymore.”
e Center for Musculoskeletal Research, a joint eort 
primarily involving investigators from the Department of 
Orthopaedic Surgery and the Department of Medicine’s 
Division of Bone and Mineral Diseases, is located in the 
BJC Institute of Health at Washington University School of 
Medicine. In all, the center includes investigators from 54 
laboratories. Not all of those laboratories are housed in the 
new space, and not all of those investigators work mainly 
with the muscles of the skeleton, but all are contributing in 
some way to an interdisciplinary eort to better understand 
the biologic causes that underlie skeletal problems.
“We have a historic interaction because most of us used to 
be housed in the Yalem Research Building,” says Sandell, who 
directs the NIH-funded program that supports the center’s 
core activities. “We had collaborations between investigators 
that allowed us to put together a center grant, and that greatly 
facilitated the creation of a center on this oor. Now we hope 
to launch a number of major projects that will help us diag-
nose and treat bone and connective tissue problems earlier  
so that we can prevent more serious problems later on.”
Like other oors in the Institute, workspace in the new 
musculoskeletal center is organized with cores in the center  
and laboratories surrounding those cores. Investigators’ 
oces line a hallway along the north side of the building.
It’s designed, says Civitelli, so that investigators in the 
center will see each other… a lot. “All of this didn’t just come 
out of the blue,” he explains. “is is the end of a long process 
of nurturing trainees, attracting investigators to this eld, 
and building infrastructure.  
And the way the space is designed — 
with open labs and open administrative 
suites — it’s natural to bump into one 
another on a daily basis, which we 
believe will spur new collaborations 
across disciplines and foster creativity 
within the research base.” 
Other key members of the center 
include associate directors Matthew J. 
Silva, PhD, and Steven L. Teitelbaum, 
MD. Deborah V. Novack, MD, PhD, 
directs a core devoted to microscopic 
and molecular analysis of bone, muscle,  
cartilage, tendons and ligaments, while 
David M. Ornitz, MD, PhD, and Fanxin 
Long, PhD, lead a mouse genetic core. 
One of the center’s investigators  
produces mice with genetic traits that 
mimic various bone and connective  
tissue diseases, while other researchers 
are developing animal models to nd 
better ways to regenerate bone, cartilage and muscle.
Ultimately, all of the studies will provide not only a better 
understanding of the biology of skeletal problems, but more 
insight into multiple disorders and how they interact. But it 
all starts with individual investigations.
Civitelli’s primary research focus is osteoporosis. As with 
other problems, he says it once was true that many cases of 
osteoporosis were discovered only aer a fracture. Now it’s 
possible to screen for weakening of bones long before they 
break. Doctors can use a machine called a DXA scanner 
(Dual-energy X-ray Absorptiometry) to measure bone min-
eral density and determine who is at risk for fractures. e 
center also has a small DXA scanner and other more sensitive 
techniques to study bone structure and strength in mice. By 
studying how bone cells work, investigators are developing 
new approaches by which weak bones can be made stronger.
Sandell focuses on osteoarthritis. For the most part, early 
diagnosis of osteoarthritis isn’t yet possible. Patients don’t go 
to the doctor until they’re already having pain and stiness. 
But there are some known risk groups.
“Half a million people have arthroscopic knee surgery 
each year to treat torn meniscus cartilage,” she says. “When 
those injuries occur in young people, they’re likely to 
develop arthritis later in life. So we have to nd some way to 
repair these injuries, other than just treating the structural 
problem in the knee with surgery. We need to understand 
what’s going to happen to that person 10 or 20 years later.”
at expanded understanding is the center’s reason for 
existence. Although not all associated investigators are  
pulling in a single direction, working together will allow  
the researchers to better understand what goes wrong  
not only in osteoporosis and osteoarthritis, but in other  
musculoskeletal problems.
Intricate computer scans offer inside views  
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Serving a Need
An unspeakable problem. An underserved population.
An undeterred physician who championed their cause.
A tree-lined dirt
road leads to a
new hospital for
African women.
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or L. Lewis Wall, MD, a dream has come true. 
For almost 20 years, he worked doggedly to build a 
hospital in one of the world’s poorest countries to treat 
women with a devastating childbirth injury. His dream 
became reality this past February, when the 42-bed Danja 
Fistula Center opened in Niger, a landlocked, arid country  
in West Africa. e facility is dedicated to repairing obstetric 
stulas, childbirth injuries that result from untreated pro-
longed labor, which leave women — and oen girls —  
with a complex mixture of medical and social problems.
“It was wonderful to be there that day,” says Wall,  
professor of obstetrics and gynecology and of anthropology. 
“is hospital may seem small by American standards, but 
it will make a huge dierence in the lives of so many women 
who have suered needlessly for too long.”
Obstetric stulas are holes between body cavities that 
open up following severe tissue damage. ey occur in 
women of all ages but are more common among those  
who marry young and whose narrow pelvises make them 
susceptible to childbirth trauma. In developing countries, 
where women tend to give birth at home rather than in a 
hospital, days of pushing during dicult labor can result  
in terrible injuries.
Fistulas can form between the vagina and the urinary 
tract or rectum. e result is extremely unpleasant; women 
are le steadily leaking urine and sometimes feces. While 
the condition can usually be xed with surgery, a lack of 
health care options leaves many who suer in this way  
with no hope of recovery.
To make matters worse, many African women who 
develop stulas are divorced by their husbands, cast out 
by their families and must eke out a meager living with no 
marketable skills. Oen, they are forced to live humiliating, 
desolate lives on the edge of their villages.
“When these women get a stula, life is basically over 
for them,” Wall says. “ey become social pariahs. With an 
inexpensive surgical repair, we are able to give them back 
their life and dignity. It’s astonishing.”
Lewis first encountered the problem of stulas while  
working as an anthropologist in northern Nigeria on a 
Fulbright-Hays fellowship. Eventually, he decided the world 
needed doctors more than it needed anthropologists. Aer 
graduating from medical school, he became fascinated by 
urogynecology, a subspecialty that treats women who have 
urinary or fecal incontinence and prolapse of the vagina, 
bladder or uterus.
In Niger, the largest nation in West Africa, a serious health problem
went largely untreated until recently. L. Lewis Wall, MD, and his wife,
Helen (far left, above), donned traditional African garb for the open-
ing of the Danja Fistula Center earlier this year. The new facility offers
hope to thousands of women who have suffered severe injury during
childbirth. Accommodations for patients’ families (far right, above)
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In 1995, aer visiting a large stula hospital in Ethiopia, 
Wall envisioned opening a similar facility in West Africa, 
where stulas are prevalent.
He founded the nonprot Worldwide Fistula Fund to 
raise money to construct hospitals to repair stulas. e 
fund has helped support and build a number of stula 
centers in Africa. It also has provided money to train local 
doctors to perform the surgical procedure and to help raise 
awareness of the problem.
In Niger, among the scattered grasslands on the edge of the 
Saharan desert, people grow millet and raise sheep, cattle 
and goats. e majority of people live on less than $1 a day. 
ere are very few personal or private resources for medical 
clinics or hospitals, so getting the Danja Fistula Center built 
was much more dicult than Wall originally anticipated. 
“I thought I was fairly realistic because I had lived in West 
Africa for two years,” he says. “But we had to contend with 
unexpected obstacles — bureaucratic hassles, insects, a lack 
of communication and supplies, and people who thought 
their own interests would be threatened by such a facility.”
He also had to raise about $1 million. 
Large contributions from the Trio Foundation of  
St. Louis, South African musician Dave Matthews and an 
executive at Merrill Lynch helped the Worldwide Fistula 
Fund reach its goal. e fund also received many small per-
sonal donations, including $35 from a potluck hosted by a 
group of elderly women in New York. 
“is was not my individual achievement,” says Wall.  
“It was a result of the eorts of thousands of people.” 
Mark J. Manary, MD, the Helene B. Roberson Professor  
of Pediatrics, understands some of the obstacles Wall faced 
in getting the hospital built. Over the past 15 years, Manary 
has spent a great deal of time in Africa, where he developed 
Project Peanut Butter, a non-prot organization that produces 
a peanut-butter mixture to treat children with malnutrition.
“Lewis’ work removes a huge burden, a permanent scar, 
from the lives of thousands of African women,” Manary says. 
“I admire his commitment and persistence.”
Each year, about 1,000 women will have stula surgery in 
the new facility, which is aliated with an existing leprosy 
hospital run by a Christian missionary organization. Some 
will travel hundreds of miles by truck or bus to get there.
Aside from repairing stulas, the hospital will oversee 
outreach eorts to promote maternal health and reduce 
childbirth deaths. It also will educate women about micro-
nance to teach them about business and empowerment.  
e new hospital is part of a grand vision to eradicate  
stulas worldwide by building stula centers that will serve 
as focal points for maternity care and public health outreach 
in the world’s poorest countries.  
“For starters, we hope this hospital will help countless 
women and alleviate human suering,” Wall says. “We also 
hope it will advance women’s rights and gender equality. 
ere still is a lot of work to do. But for now, I’m just going 
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e surgical mesh looks like gauze but feels sticky, like 
a spider web. It is typically composed of multiple layers of 
nanobers and can be cut to size for dierent uses. Once the 
mesh is placed in the body, cells grow along the individual 
nanobers, which gradually degrade in nine to 12 months, 
leaving only the body’s own tissue in their place.
One advantage of the new technology is that dierent pat-
terns of nanobers can be created in the mesh to promote 
the healing of dierent kinds of wounds. For example, in 
a starburst pattern used to repair ulcers and other circular 
wounds, the nanobers originate from a central point and 
radiate outward. is encourages cells to migrate and grow 
toward the center of the wound. For linear defects like tears 
and incisions, nanobers can be aligned perpendicular to 
the wound, encouraging cell growth across the injury, which 
provides reinforcement to the new tissues.
MacEwan is currently evaluating the product in animal 
models, a rst step toward gaining U.S. Food and Drug 
Administration approval. Preliminary studies indicate the 
nanober material is safe and eective; MacEwan is hopeful 
that clinical trials in patients will begin later this year.
For now, MacEwan is nishing his doctorate and has two 
years le before he receives his medical degree. He’s plan-
ning a career in academic medicine, where he can spend 
time in the laboratory and the operating room. ere, he 
hopes to use the nanober surgical meshes he developed to 
improve the care and surgical outcomes of his own patients.
“At Washington University, I have continually focused  
on moving discoveries beyond the laboratory,” MacEwan 
says. “I hope to see this technology have a positive impact  
on many patients. Nothing would be more thrilling.”
Existing surgical mesh used to repair the protective membrane 
that covers the brain and spinal cord is thick and sti, making 
it dicult to work with. But the novel material MacEwan and 
Xie developed is thin and exible and more easily integrated 
into the body’s own tissues.
“It’s almost like a cloth,” MacEwan says. “But it’s designed 
on a nanoscopic scale. To put that into perspective, every 
thread of the mesh is hundreds to thousands of times smaller 
than the diameter of a single human cell.”
e technology’s promise has caught the attention of 
the business world. In 2011, MacEwan won the Olin Cup, 
sponsored by Washington University’s Skandalaris Center 
for Entrepreneurial Studies. In June he won the Licensing 
Executives Society Foundation’s International Graduate 
Student competition in London, and last November, the  
Idea to Product Global Competition in Stockholm. e  
winnings of more than $100,000, along with other invest-
ments and in-kind services, have helped MacEwan get the 
company o the ground.
e nanober material developed by MacEwan and 
Xie, now a senior scientist at Marshall University in West 
Virginia, along with collaborators Younan Xia, PhD, the 
James M. McKelvey Professor of Biomedical Engineering, 
and Zack Ray, MD, now an attending neurosurgeon at the 
School of Medicine. MacEwan has worked closely with 
Washington University’s Oce of Technology Management, 
which has led patents on the technology.
“We’ve taken the whole idea of surgical mesh and pushed 
it into a new direction,” MacEwan says. “It’s not just a foreign 
material you’re putting into the body. e nanofabricated 
nature of the mesh creates a scaold that cells can easily  
penetrate and populate to recapitulate the body’s tissues.”







A student’s “big” vision will help surgeons and patients alike
Matthew R. MacEwan is no ordinary medical student. e neurosurgeon-to-be,  
a student at the School of Medicine, also is pursuing a doctorate in biomedical 
engineering at Washington University. And, at 29, he recently started his own 
local company, Retectix LLC, aimed at revolutionizing the surgical mesh used  
in operating rooms worldwide.
e company’s lead product, invented by MacEwan and Jingwei Xie, PhD,  
a former postdoctoral researcher in engineering, is a synthetic polymer mesh  
made of synthetic nanobers. e mesh was developed to repair defects in the 
membrane surrounding the brain and spinal cord, but also could be used to 
mend tissues as well. e nanober material has the potential to make operations 
easier for surgeons and reduce the rate of complications experienced by patients.
Co-inventor of promising nanofiber: 
Matthew R. MacEwan
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Diverse physicians honored with lasting legacies for education
B Y  S T E P H A N I E  S T E M M L E Rmentor memorial funds
Leaving their marks 
Walter F. Ballinger, MD, embodied the spirit of rigorous and broad-based learning at Washington University School of Medicine. Former head of the Department of Surgery, 
Ballinger relished his role as an educator.
“He thrived on teaching and cared deeply about training the next  
generation of surgeons,” says his wife, Mary Randolph Ballinger.  
“He always wanted to bring out the excellence in their talents.”
Timothy J. Eberlein, MD, the Bixby Professor and head of the 
Department of Surgery says, “Dr. Ballinger oen said that training the 
next generation of surgeons would be the most important, and among 
our most challenging, tasks.”
So it was a tting tribute that shortly before Ballinger passed away  
last year at the age of 85, one of his rst surgical interns, Gordon W. 
Philpott, MD, suggested a fund that would support the establishment 
of the Dr. and Mrs. Walter F. Ballinger Surgical Academic Education 
Program. e initial endowment was funded by the Ballingers, and  
former residents and friends made generous contributions.
Four distinguished former  
faculty honorees, left to right:  
Walter F. Ballinger, MD, John P. 
Boineau, MD, Paul R. Manske, MD,  
and J. Neal Middelkamp, MD
123225_MAD_26-36_CS5.indd   26 8/16/12   1:54 PM
Another beloved mentor and colleague, Stuart S. Sagel, MD, 
will be recognized in the Mallinckrodt Institute of Radiology 
with a conference room named in his honor. “Residents, fel-
lows and faculty members alike beneted from his excellence 
as a clinician and teacher for decades,” says R. Gilbert Jost, 
MD, the Elizabeth E. Mallinckrodt Professor and head of 
the Department of Radiology and director of Mallinckrodt 
Institute of Radiology. Teaching conferences will be held in 
the renovated space and will serve as an ongoing reminder 
of Sagel’s many contributions. Sagel passed away in 
November 2011, and the Mallinckrodt Institute of Radiology 
will keep his legacy alive through this constant reminder. 
11th annual J. Neal and Lois Middelkamp Lecture. e  
lectureship rotates topics between Middelkamp’s passions 
— infectious diseases and medical education. “e estab-
lishment of this lectureship enables us to bring in national 
and world leaders to inform and inspire the Washington 
University community,” says Alan L. Schwartz, PhD, 
MD, the Harriet B. Spoehrer Professor and head of the 
Department of Pediatrics. e Middelkamps established the 
endowed fund in 2001 and, upon his death in November 
2011, gis in tribute to his accomplishments and mentorship 
were directed to the fund. e comments from former stu-
dents and residents reect a tremendous depth of gratitude 
for the role he played in their lives.
B Y  S T E P H A N I E  S T E M M L E R
Leaving their marks e program enables the Department of Surgery to expand the knowledge of surgical training beyond the clinical prac-tice of surgery to include topics such as ethics, public health 
and health care delivery. 
“is is a way to honor the school and the person and to 
benet society through advancement of education,” says 
Philpott, emeritus professor of surgery and a former member 
of the university’s Board of Trustees. “It ts with Walter’s 
own passion of continuous learning.”
Washington University School of Medicine has received 
many gis to honor faculty who have been outstanding men-
tors and colleagues. e outpouring of generosity for recent 
memorial gis reects the school’s collegial spirit. 
In the Cardiovascular Division, the rst John P. Boineau 
Lecture was held in April 2012 to honor Boineau’s contribu-
tions in the elds of cardiothoracic surgery and cardiology. 
e lecture fund was created through the generosity of  
current and former faculty and former residents.
“Dr. Boineau made substantial contributions to the Cox-
Maze procedure for the treatment of atrial brillation, the 
most common arrhythmia that we treat,” says Douglas L. 
Mann, MD, Lewin Professor and chief of the Cardiovascular 
Division. “is procedure formed the basis for ablation 
therapy and is practiced by electrophysiologists on a daily 
basis. Dr. Boineau’s contributions will continue to be felt for 
the next decade, and likely well beyond that.” 
In the Department of Orthopaedic Surgery, the Paul 
Manske, MD Resident Learning and Teaching Center debuts 
next year to honor his memory. Manske, the former chair-
man of the department, died in April 2011. 
“We are dedicating this space in honor of 
Dr. Manske because he was a world-renowned 
hand surgeon and a true gentleman who also 
was a highly eective teacher. is center will 
enable us to honor his legacy and his life here 
at the medical center where he spent nearly 
his entire career,” says Richard H. Gelberman, 
MD, the Fred C. Reynolds Professor and head 
of the Department of Orthopaedic Surgery. 
“It will be a state-of-the-art learning center 
for residents and house sta encompassing 
individual computer carousels, an anatomical 
dissection facility, and an arthroscopy and surgical skills 
simulation center.”  
Former orthopaedic surgery resident Bruce A. Bollinger, 
MD, was among those who made a memorial gi to 
recognize Manske. “Dr. Manske was an excellent sur-
geon, research scientist and educator and was always very 
approachable with questions or issues,” says Bollinger.  
“I feel I owe much to him and the rest of the faculty during 
my time at Barnes, and I hope the new center will facilitate 
education and training through easier access to information 
and hands-on simulator equipment.”
In November, the Department of Pediatrics will host the 
Stuart S. Sagel, MD



















Washington University School of Medicine has  
received many gifts to honor faculty who have  
been outstanding mentors and colleagues.  
The outpouring of generosity for recent memorial  
gifts reflects the school’s collegial spirit.
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An eye for patient care
John F. Hardesty, MD, spent his career caring for the needs of visually impaired children and their families. He dedicated his life to improving the quality of life for all with whom he came in 
contact. It is in his memory that his daughter, Jane Hardesty Poole, 
established the John F. Hardesty, M.D. Distinguished Professorship 
in Ophthalmology and Visual Sciences. Hardesty’s life and work were 
honored on May 31, 2012, at the installation ceremony and lecture of 
R. Lawrence Tychsen, MD, the inaugural professorship holder.  
Hardesty (1887–1953) was an eminent St. Louis ophthalmologist, 
teacher, writer and war hero whose heritage dates to Colonial and 
early Missouri settlers. He received bachelor of science and doctor of 
medicine degrees simultaneously from Saint Louis University in 1914. 
Following his graduation from medical school, he spent two years as 
an intern and later a resident at St. Louis City Hospital.  
Pediatric ophthalmologist R. Lawrence 
Tychsen, MD, examines the eyes of 
young patient Clark Griffin.
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1983, followed by fellowships at the University of California 
San Francisco (pediatric and neuro-ophthalmology) and 
the Smith-Kettlewell Institute, San Francisco. He also was 
a neuroscience research postdoc both at the National Eye 
Institute/National Institutes of Health (NIH) and at UCSF. 
From 1985 to 1989, Tychsen served in the U.S. Air Force 
as a ight surgeon/pediatric ophthalmologist at the School 
of Aerospace Medicine and the Wilford Hall Medical Center, 
San Antonio. 
In 1989, Tychsen joined the Washington University 
School of Medicine faculty, where he is professor of ophthal-
mology and visual sciences in pediatrics and professor of 
anatomy and neurobiology. He is ophthalmologist-in-chief at 
St. Louis Children’s Hospital. 
Tychsen’s clinical work focuses on three topics: surgical 
repair of vision in children with ocular and brain damage 
(including prematurity, cerebral palsy, Down syndrome and 
autism), refractive surgery (excimer laser and intraocular 
implants) for children who have major diculties wearing  
eyeglasses or contact lenses, and eye muscle surgery for  
children and adults who have crossed eyes (strabismus) and 
eye movement abnormalities (nystagmus). He is principal 
investigator on NIH R01-funded studies of visual brain  
maldevelopment and repair in infant primates, as well as 
clinical studies of visuomotor abnormalities in cerebral palsy 
and pediatric refractive surgery. 
Tychsen has published more than 200 clinical and basic 
science journal articles or book chapters. He serves on the 
editorial boards of several journals, as well as panels for 
national and international ophthalmology associations, the 
National Eye Institute of the NIH, the Pediatric Eye Disease 
investigator group, and the Food and Drug Administration.  
Tychsen has mentored more than 30 undergraduate and 
medical students over the course of his teaching career and 
has received numerous awards, lectureships and honors.
“It is humbling and inspiring to be named as the rst 
Hardesty professor,” Tychsen says. “Dr. Hardesty was not 
only an accomplished ophthalmologist, but beyond this a 
great husband and father, and a brave patriot. He knew that 
he had been called to a vocation, not just a profession, and 
that he was the instrument of a purpose. I’ll embrace his 
spirit in the work of the professorship that his daughter,  
Mrs. Poole, has so generously provided.”
Hardesty enlisted in the U.S. Army Medical Corps and 
was later transferred, at his own request, to the Seaforth 
Highlanders in the British Military Service. In this capacity,  
he served on the front lines of World War I until March 1918, 
when he was captured by the German army and held at 
Baden-Baden for eight months as a prisoner of war until the 
armistice. He received an honorable discharge as a captain  
in March 1919. 
Hardesty joined the Saint Louis University School of 
Medicine faculty in 1920, advancing to senior instructor  
in 1928, assistant professor in 1931, and associate professor  
in 1934. He served with distinction in that role until 1953.  
During his tenure, he served as acting chair of the school’s 
Department of Ophthalmology.
Hardesty’s pioneering 1934 thesis for membership in  
the prestigious American Ophthalmological Society was 
titled “Treatment of Glaucoma by Systemic Measures.” 
Although the rst recorded treatments for glaucoma date 
to the mid-19th century, Hardesty performed research and 
published papers on treating the disease using “systemic” 
medication, drugs introduced to the body intravenously or 
subcutaneously. is represented the rst attempt to treat 
glaucoma in systemic form. Hardesty’s idea of using epineph- 
rine to treat glaucoma is still in use today in eyedrop form, 
and his work was foundational to the development of the 
oral drug Diamox in the 1950s by Bernard Becker, MD, at 
Washington University.
Oen described as “a gentleman and a scholar,” Hardesty 
le among his papers a list entitled “ings I Wish I had 
Known Before I was Twenty-One.” e last item noted: “the 
greatness of the opportunity and joy of serving a fellow man.” 
Nothing guided the life and work of Hardesty more than this. 
 “My father gave so much of himself to help individuals 
from all walks of life to retain their sight,” says Poole, a 1961 
graduate of Washington University. “He was very modest 
and humble, yet a towering gure. I am so pleased that I can 
honor him in this way.”
The inaugural recipient of the Hardesty Professorship,  
R. Lawrence Tychsen, MD, graduated from Georgetown 
University with majors in biology and philosophy, receiving 
his medical degree from Georgetown in 1979. He nished 
residency training at the University of Iowa Hospitals in 







Washington University  
Chancellor Mark S. Wrighton,  
R. Lawrence Tychsen, MD,  
Jane Hardesty Poole and School of 
Medicine Dean Larry J. Shapiro, MD.
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Members of the Class of 1962 welcomed this year’s graduates into the medical profes-sion and a unique camaraderie of col-
leagues with a new Washington University School 
of Medicine alumni pin. e pins were presented 
at the Alumni Awards Banquet on April 28, 2012, 
marking the culmination of a busy Reunion  
weekend of activities for alumni and guests. 
e idea behind the pin and the beginning of a 
new tradition was sparked by conversations with 
alumni and Washington University physicians 
who have alumni pins from other medical schools. 
e pins can be worn on white coats and allow 
alumni to subtly display school pride.  
e pins also presented an opportunity to 
introduce new graduates to the Washington 
University Medical Center Alumni Association, 
while bridging the 50-year gap that separates 
the Golden Anniversary and current graduating 
classes. Advancements in medical training, treat-
ments and technology make the experiences of 
both groups of physicians very dierent, but the 
common bond of Washington University repre-
sented in the alumni pin unites them.
e 50th Class Speaker, William H. Gondring 
III, MD, introduced the tradition and announced 
that he and his fellow classmates would present 
MD Class of 1962 begins new Reunion tradition
reunion
Interested in seeing more of the people, 
events and activities of MD Reunion 2012? 
medicine.wustl.edu/reunion/photogalleries 
 
B Y  J U L I E  M A H O N E Y
each of the graduates with a pin as a token of  
congratulations. e 2012 graduates surrounded 
the Class of 1962 and a hush fell over the ball-
room. Heartfelt comments and genuine grati-
tude were expressed by the young physicians to 
the senior alumni. It was an intimate moment 
between individuals, but its impact was palpable 
throughout the entire ballroom.  
A general sense of awe and respect for one 
another was evident. e new graduates took the 
pinning ceremony seriously, with a reverence for 
the older alumni that might at rst come as a 
surprise. But then again, the respect they demon-
strated is a natural byproduct of the long years of 
training, the unique skill sets required of physi-
cians, and the important regard held for the men-
tors who guide students through the process of 
medical education.   
“I remember admiring the Class of 1962 and 
especially noting their sense of humor and ease of 
interaction with all of us,” reects 2012 graduate  
Tara C. Jackson, MD. “ey were encouraging 
about our future prospects and careers. I enjoyed 
the support and connection we all felt to the 
alumni. It was inspirational! ey were once in 
our shoes and it means the world to see where 
they are now.
“Seeing how they kept in touch with their 
class at Washington University and maintained 
the informal, friendly relationship they had as 
students 50 years ago was also priceless,” says 
Jackson, “and very encouraging during this  
emotional time in our lives.”
According to Gondring, the ceremony  
represented more than a transfer of 50 years of 
health care commitment from one medical class 
to another. “It also represents recognition of 
new skill sets obtained by the new graduates as 
a continuation of a similar learning experience 
obtained by the presenting alumni,” he says.
e pinning ceremony, a huge success, will now 
be a featured event at Reunion, and takes its place 
alongside long-held School of Medicine traditions 
such as the White Coat Ceremony and Match Day. 2012 graduate Mark D. 
Mangano, MD, visits with 
members of the Class of 
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James Russell Hornsby’s company, Cepia Inc., was founded on the premise that suciently advanced technology is indistinguishable  
from magic. With that in mind, he has created a 
world of electronic toys that entertain and delight 
children and adults alike.  
Chief among the company’s successes are the 
popular robotic Zhu Zhu Pets, included on Time 
magazine’s “All-TIME 100 Greatest Toys” list.  
But Hornsby’s interest in technology doesn’t end 
with his devotion to toys; he’s also fascinated  
with how technology can spur advancements in 
medical research, with a particular focus on  
curing cancer and other major diseases. 
A former undergraduate parent, his aliation 
and appreciation of Washington University were 
already solidied. As an avid supporter of various 
community philanthropic organizations, the  
St. Louis-based Hornsby expressed interest 
in building a relationship with the School of 
Medicine that would support medical science and 
the groundbreaking achievements of the school’s 
physician-scientists. 
at determination to give back resulted 
in the establishment of the J. Russell Hornsby 
Professorship in Biomedical Sciences. is  
signicant gi will be used to support the work  
of the professorship’s inaugural recipient,  
Samuel A. Wickline, MD, professor of medicine, 
of physics, of cell biology and physiology, and of 
biomedical engineering.
A blending of entrepreneurial spirit
professorship B Y  M I C H E L E  H O E F T
Samuel A. Wickline, MD, 
the inaugural recipient 
of the J. Russell Hornsby 
Professorship in  
Biomedical Sciences
A successful entrepreneur in his own right, 
Wickline established the Washington University 
Consortium for Translational Research in 
Advanced Imaging and Nanomedicine, known 
as  C-TRAIN. Located at the St. Louis CORTEX 
Center, C-TRAIN is devoted to diagnostic and 
therapeutic development of nanotechnology for 
broad-based clinical applications, in conjunction 
with corporate and academic partners.  
Mirroring Hornsby’s premise, Wickline’s  
pioneering nanoparticle research has shown  
that truly advanced, groundbreaking technology 
can be used to create another type of magic — 
changing the way medical diagnoses are made  
and improving the safety and ecacy of drug 
treatment, thereby benetting patients.
Imagine being able to replace multiple  
medical tests, scans and treatments with a single 
injection. at’s the promise oered by nano-
particles, extremely small, bead-shaped units that 
can become carriers of medicine. Using these tiny 
particles, doctors will be able to locate disease sites 
deep within the body and at the same time deter-
mine their size, shape and molecular features. 
ey can then adapt the nanoparticles to deliver 
therapeutic drugs exactly where needed and  
personalized to each patient.  
In addition to his research, Wickline created 
the Siteman Center of Cancer Nanotechnology 
Excellence at the Alvin J. Siteman Cancer Center 
at Barnes-Jewish Hospital and Washington 
University School of Medicine. e center is 
devoted to nanomedical therapeutics for cancer.  
He also established the St. Louis Institute of 
Nanomedicine, a consortium of academic and 
commercial partners devoted to enhancing  
regional infrastructure for the translational 
advancement of nanotechnology in medicine.  
Hornsby’s entrepreneurial spirit is a perfect 
match for Wickline’s research eorts. e  
J. Russell Hornsby Professorship in Biomedical  
Sciences and Wickline’s development of nano- 
particle technology will continue to give hope  
that one day we will see the magic and no longer 
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Benjamin Milder, MD 39
Milder published a sixth book of poetry, 
From Adolescence to Senescence–A Life in 
Light Verse, in 2010.
1940 S 
Robert Royce, MD 42
Royce is retired and enjoying life to the 
fullest. His interests include golf, bridge, 
ecology, and being on the ranch.
George Prothro, MD 45
Prothro enjoys traveling and volunteer 
work. He has participated in a program 
which makes unused, sealed prescrip-
tions from nursing homes available to  
the indigent.
Stanley Wald, MD 46
Wald, though retired, participates in life-
long learning courses and volunteers at  
a local grade school.
Theodore Bryan, MD 47
Bryan retired from practice in 1998. His 
hobbies include reading and the occa-
sional round of golf. He continues to enjoy 
his time with his wife of 62 years, Bertha 
“Benny” Benadine.
1950 S 
Edgar Draper, MD 53
Draper was the 50 Year & Life Medal and 
Distinguished Fellow Award recipient from 
the American Psychiatric Association in 
May 2011.
J. Roger Nelson, MD 53
Nelson wrote and published a novel, The 
God Whom Moses Knew, in August 2010.
Rillah Owen, NU 54
Owen retired in 1997 and has moved to 
Lewes DE. She took up watercolor (plein 
air painting), volunteers for the risk man-
ager at Beebe Hospital in Lewes, and is 
active in swimming, traveling, baking and 
playing bridge. Owen belongs to three 
art leagues and has gone on a jazz cruise 
every year for the past seven years.  
Donald Harkness, MD 58
Harkness is still playing tennis several 
times a week. Last June he took his  
12-year-old granddaughters to Japan.  
He is still helping in a hematology course.
1960 S 
John Crane, MD 64
Crane is still working part-time. He is 
enjoying life, doing some (non-medical) 
writing, traveling and sailing his old 
Pearson P-30. 
Michael Reif, MD 68
Reif retired from private practice in 2004. 
He spent more than six months in North 
Carolina’s Blue Ridge Mountains. He has 
been married 47 years and has eight 
grandchildren.
Penelope Shackelford, MD 68
Shackelford is still restoring land in 
Wisconsin and enjoying her grandchildren.
Michael Pacin, MD 69
Pacin has been awarded the Intercultural 
Human Rights Award at St. Thomas 
University School of Law in recognition 
of his commitment to diversity, the fight 
against human trafficking, and assistance 
to those in need in the community. Pacin, 
who is the founder and was the CEO for  
35 years of the Florida Center for Allergy & 
Asthma Care, expanded his practice from 
two to 17 offices and implemented a  
policy of “giving back” by providing afford-
able or free medical care to indigent 
patients. He continues to work full time, 
caring for patients, administering a large 
practice, and serving his community.  
1970 S 
Bruce Broudy, MD 74
Broudy was elected the 2012 president of 
the Lexington Medical Society. He resides 
in Lexington KY, where he works in the 
area of pulmonary medicine.
Charles Newton, MD 75
Newton is currently a private practice  
cardiothoracic surgeon in Huntsville AL.  
He celebrated his 30th anniversary as  
a surgical subspecialist by retiring the  
scalpel on April 15, 2012. In June, Newton 
and his wife, Ann, a former scrub nurse 
from Brigham and Women’s Hospital in 
Boston, moved to Tampa FL, where he 
began a palliative medicine fellowship at 
University of South Florida. He is excited 
with this invitation to redirect his medical 
career, enabling him now to devote his 
energy and expertise to ameliorating the 
suffering of the terminally ill.
Thomas Cooper, MD 76
Cooper and his wife, Linda Loney, MD 76, 
are both retired. They recently moved to a 
condominium in the south end of Boston 
from the suburbs, which they are very 
happy about.
1980 S 
Linda Douglas, MD 82
Douglas returned to private practice  
after 20 years in medical education and 
residency education at Rush Medical 
College and Medical College of Wisconsin. 
She is happy to now have time to con-
centrate on patients, her kids and life.  
Her children, Karen and Daniel, are 25  
and 21, respectively.  
Gary Chun, MD 84
Chun is trying to be a jazz drummer in  
his free time.
John Donovan, MD 87
Donovan has climbed Mt. Kilimanjaro and 
participated in five surgical missions in 
South America in the past five years. His 
hobbies include biking, swimming and 
watching his daughters play softball.
Rosalie Hagge, MD 88
Hagge is an associate clinical professor  
of radiology and nuclear medicine at  
the University of California, Davis  
Medical Center.  
Robert McMahon, MD 89, HS 92
Robert McMahon, JD, MD, a gastro- 
enterologist, has been elected 2012  
president of the St. Louis Metropolitan 
Medical Society, the association repre-
senting physicians in the St. Louis area. 
He is in private practice with St. Louis 
Gastroenterology Consultants in south  
St. Louis County.
Autu
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1990 S 
Grant Hoekzema, MD 92
Hoekzema is in his 12th year as director 
of the Mercy Family Medicine Residency 
program and a clinical professor of fam-
ily medicine at Saint Louis University. His 
hobbies include traveling and watching 
his children grow and develop career 
plans of their own. He was elected presi-
dent of the Association of Family Medicine 
Residency Directors for this coming year.
Kristin Kjensrud, PT 92
Kjensrud and her partner have a son, 
Nathaniel, 2. She teaches in the physical 
therapy assistant program at Mt. Hood 
Community College.
Corina Norrbom, MD 94
Norrbom spent July 2009 through 
September 2010 working as a general 
practitioner in New Zealand. She found it 
to be a wonderful experience, learning a 
little and teaching a little every day. This 
opportunity to experience another health 
system firsthand was invaluable to her.
Louis Kuchnir, MD 97
Kuchnir and his wife, Karen, are settled 
in the suburbs west of Boston with their 
children, who are now in 4th, 7th, 9th and 
10th grades. He is now in his 11th year of 
owning his private practice.  
Dina Levin, HS 97
Levin moved to central Vermont, where 
she is an ob/gyn at Gifford Medical Center. 
She has two sons.
Richard Tsai, MD 98
Tsai is the medical director and a practic-
ing clinician at Providence Medical Group.
2000 S
Linda Cummings, MD 01
Cummings and her husband enjoy  
spending time with their son Matthew, 
who is about to turn 2.
Betsy Peterson, MD 02
Peterson is founder and president of 
Community Pediatrics, SC in Beaver Dam 
WI and Waupun WI. She started a pediatric 
clinic in a town east of Madison WI that 
had no previous pediatrician. In the past 
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seven years, it has grown to now have 
two pediatricians, two pediatric nurse 
practitioners, and two locations with nine 
additional employees and more than 
3,000 patients. Peterson is involved with 
the Wisconsin Chapter of the American 
Academy of Pediatrics and the Section on 
Administration and Practice Management.  
She also cheers for Wisconsin sports —  
Go Badgers and Go Packers!
Kristen Bruno, MD 03
Bruno completed four years of pediatrics  
in the Air Force and is now working as a 
pediatric hospitalist with GlennonCare.
Stacey Rubin, MD 06
Rubin is a generalist ob/gyn at Crozer 
Keystone Health System outside 
Philadelphia PA. She focuses on pediatric 
and adolescent gynecology and recently 
accepted a position as associate residency 
director of Crozer’s ob/gyn residency  
program. 
In Memory
Thomas Geppert, MD 43
Geppert, 92, died on Dec. 31, 2011. He is 
survived by five children and numerous 
grandchildren and great-grandchildren.
Robert Stowell, PhD 44, HS 44
Stowell, a world-renowned pathologist 
who was an early leader of the UC Davis 
School of Medicine, died Nov. 20, 2011. He 
was 96. Stowell joined UC Davis in 1967 
as founding chairman of the pathology 
department and was vice chairman of the 
medical school’s first admissions commit-
tee. In 1969, he was appointed director of 
the UC Davis Primate Center. He returned 
to the pathology department after two 
years and retired in 1982, but continued 
teaching as a volunteer until 2001. He  
was an influential leader of national and 
international pathology groups.
Rosemary Etherton, NU 46
Rosemary Etherton, 85, died on Sept. 5, 
2011. She continually gave of herself and 
was an example of unconditional love 
and grace. Her children and grandchildren 
counted on her faithful prayers in every 
situation. She is survived by her sister,  
four daughters and 11 grandchildren.
Jack Davis, MD 47
Davis died on Nov. 28, 2011. He was 89. 
An internal medicine specialist, he was 
a member of the AMA for 50 years and a 
founder of the Raytown Clinic. He prac-
ticed medicine at both Research Medical 
Center and Baptist Memorial Hospital. He 
was a lifelong sports fan — particularly 
of the Kansas City A’s, the Royals and the 
Chiefs. He was a voracious reader of jour-
nals and books. He was a member of the 
Raytown Christian Church. 
Mary Devous, NU 48
Devous, 84, died on Oct. 10, 2011. She 
retired from more than 25 years of service 
in the Veterans Administration as a nurse 
and nurse administrator. She also served 
in many capacities in the DAV auxiliary, 
the Ladies Auxiliary of Fleet Reserve 
Association, Women in Military Service 
for America, and in her church. She loved 
nursing and caring for others, but loved 
her role as mother and grandmother most. 
Patricia O’Neal, LA 44, MD 48, HS
O’Neal, a retired clinical professor of psy-
chiatry, died on Dec. 20, 2011. She was 88.  
She is survived by her husband.
Rosemary Richardson, PT 48
Richardson died on Dec. 28, 2011. She is 
survived by her husband and many nieces 
and nephews. 
Eva May Dobbins Bundenthal, NU 49
Bundenthal, 83, died on Nov. 30, 2011.  
She was a registered nurse for more than 
50 years and received the Humanitarian 
Award for Nurse of the Year from the 
Selma Medical Center. 
Sidney Jick, MD 49
Jick died on Nov. 14, 2011. He is survived 
by his wife, a daughter, and four grand-
children.  
Joseph Iwano, MD 50
Iwano died on Oct. 28, 2011. He was 91. 
After medical school and military service, 
he established a private urology practice 
with offices in Alliance and Salem. He was 
an organic gardener decades before it was 
fashionable, a skilled furniture-maker and 
photographer, as well as a teller of corny 
jokes. His extensive knowledge of history 
made travels extra meaningful. In 1988, he 
retired and moved to Mercer Island WA.
Elynor Flitz, NU 51
Flitz, 83, died on Sept. 3, 2011. She was a 
registered nurse and a nurse educator. She 
and her husband, Henry, lived in Princeton 
for many years, later moving to Texas and 
subsequently made Coralville their sum-
mer home. She is survived by her husband, 
three children and six grandchildren.
James Michael, MD 53
Michael, 83, died on Nov. 10, 2011.  
After an internship at Barnes Hospital 
in St. Louis, he was a flight surgeon in 
the U.S. Air Force. In 1960, he joined the 
Department of Internal Medicine at the 
Sheboygan Clinic. He served as presi-
dent of the medical staff of Sheboygan 
Memorial Hospital and of the Sheboygan 
County Medical Society. For many years 
he was the designated preceptor in the 
Sheboygan area for senior medical stu-
dents at the University Medical School 
in Madison. Michael retired early from 
medical practice to follow his passion for 
watercolor painting, which he taught for 
more than 30  years at the John Michael 
Kohler Arts Center. He exhibited locally 
and nationally and more than a thousand 
of his paintings hang in private and cor-
porate collections. Many were donated to 
local charity benefit auctions.
Charles Dunaif, MD 54
Dunaif died on Dec. 26, 2011. He is  
survived by his wife, daughter, and a  
niece and nephew. 
Byron Demorest, HS 54
Demorest died on Oct. 14, 2011. After 
receiving his medical degree, he com-
pleted a residency in ophthalmology 
at Washington University. He was an 
assistant clinical instructor in ophthal-
mology at Stanford University and the 
founding chairman of the Department 
of Ophthalmology at the University 
of California, Davis. He was a member 
of many organizations, including the 
American Academy of Ophthalmology for 
which he served as president. He also had 
active duty with the U.S. Navy, ending up 
as a lieutenant commander and chairman 
of the Eye Department at the Great Lakes 
Naval Hospital.
Clark Grimm, MD 57
Grimm died on Sept. 13, 2011.
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R. Wayne Neal, MD 58
Neal died on Dec. 5, 2011.
Mary Coons, OT 60
Coons, 86, died on Oct. 17, 2011. She was 
in the civil service in Nagoya, Japan, where 
her passion for antiques and collecting 
began. She returned to the United States 
to finish school and retired as an occu-
pational therapist with the VA hospital 
in St. Louis MO. She was well-known on 
Cherokee Antique Row in St. Louis, where 
she had a store.
George Dueker, MD 61
Dueker died on Dec. 4, 2011. During the 
Vietnam War he served as a flight surgeon 
with the U.S. Air Force. After two years 
on the Stanford faculty, he moved to 
Carmel CA, where he practiced urology 
for 30 years. In 2001, he affiliated with 
the Provident Group in Portland OR and 
became an avid Trailblazers fan. He never 
stopped his quest for knowledge or  
lessened his interest in the world. 
Doris Rigg, OT 62
Rigg, of Denver CO, died on Sept. 25, 2011. 
She was 78. 
Margaret Hayes, HS 66
Hayes, of Dayton OH, died on Sept. 8, 
2011. She was 84.
Thomas Banton, HS 68
Banton, 76, died on Dec. 25, 2011. He  
was an orthopaedic surgeon, associated 
with the Northland Orthopaedic Group  
in St. Louis, and served on the staff of  
De Paul Hospital and Christian Hospitals 
Northeast and Northwest. He practiced 
30 years before retiring in 1995. He also 
served his country as a captain in the  
U.S. Army. He is survived by his wife, 
daughter, son and five grandchildren.
John Black, MD 73
Black, 64, died on Dec. 1, 2011. He was an 
anesthesiologist and worked for Bowling 
Green Anesthesia at Greenview Hospital. 
He loved to cook and to attend cooking 
schools. He also enjoyed travel and was 
an avid photographer and reader. He was 
proud of his children’s accomplishments 
and of his two young grandchildren. He 
also took great pride in his King Charles 
spaniels, Kona and Hilo. Black is survived 
by his wife Toby Black, OT 71, two  
children and two grandchildren.
Mark Ginsburg, LA 73, HS 81
Ginsburg, 60, died on Nov. 11, 2011, in 
St. Louis MO. He attended Washington 
University for his undergraduate work in 
biology and returned to intern at Barnes-
Jewish Hospital after receiving his medical 
degree. Following residency, he moved to 
Florida to start a rheumatology practice 
and eventually became involved in other 
interests including Nationwide Laboratory 
Services of Fort Lauderdale FL, a revolu-
tionary diagnostic laboratory specializing 
in the needs of dialysis patients. Always 
seeking the most from life, he was an avid 
birder, a California wine expert, an aviation 
enthusiast and an astronomer. Ginsburg 
traveled extensively to South America to 
help preserve and rebuild the rain forests. 
He had an incredibly green thumb when 
it came to his beautiful orchid garden 
and also was a huge sports fan, rooting 
for the Miami Hurricanes teams. Always a 
research advocate, Ginsburg was honored 
in 1999 as a Founders Day Distinguished 
Alumni of Washington University. He was a 
member of the Board of Trustees and pro-
vided scholarships to students. He is sur-
vived by his wife, son and twin daughters.
Robert Etienne, HS
Etienne died on Dec. 23, 2011. He is sur-
vived by his wife, daughters, brother  
and sisters. His memory will be cherished 
by his grandchildren, great-grandchildren, 
nephews and a host of other family  
and friends.
Bernard Sarnat, HS
Sarnat, an eminent plastic surgeon and 
research scientist who advanced the 
understanding of craniofacial develop-
ment and the causes of facial deformities, 
died on Oct. 21, 2011 in Los Angeles CA. 
He was 99. In 1955, he began a private 
practice in plastic surgery in Beverly Hills 
CA. In 1969, he was appointed professor  
of oral biology at the UCLA School of 
Dentistry and, in 1974, he was appointed 
professor at the UCLA School of Medicine 
in the Division of Plastic Surgery. For more 
than two decades, he was chief of plastic 
surgery at Cedars-Sinai Medical Center. He 
retired from surgical practice in 1991, but 
continued writing and publishing. 
Faculty 
M. Alan Permutt, MD
Permutt, professor of medicine and of cell 
biology and physiology at Washington 
University School of Medicine, died on 
June 10, 2012, in St. Louis. He was 72. A 
faculty member since 1970 and one of 
the world’s leading diabetes researchers, 
Permutt demonstrated in 1992 that varia-
tions in the glucokinase gene could cause 
type 2 diabetes. The discovery was the 
culmination of years of connecting com-
plex genetic linkage studies and molecular 
biology to a common, chronic disease. 
Later, his studies of genes and diabetes 
led him to focus on a particularly devas-
tating form of the illness called Wolfram 
syndrome. Permutt’s laboratory identified 
a gene for the illness, which causes type 
1 diabetes, hearing loss, severe vision loss 
and hearing and neurological problems. 
In 2010, with St. Louis Children’s Hospital, 
Permutt led the effort to create the world’s 
first multidisciplinary clinic for patients 
with Wolfram syndrome, bringing them 
to St. Louis from all over the world for 
intensive testing. Because the syndrome is 
so rare, that first clinic in 2010 also repre-
sented the first time Permutt was able to 
work directly with patients with Wolfram 
syndrome and their families. Permutt 
attended Johns Hopkins University in 
Baltimore MD before earning a medical 
degree from Washington University School 
of Medicine in 1965. He later was an intern 
at Yale-New Haven Hospital and a medical 
resident as well as a postdoctoral fellow 
at the University of Washington in Seattle 
before returning to Washington University 
for the rest of his academic career. He is 
survived by two daughters, Joelle Permutt 
and Robin Winer; dear friend Rhea 
Oelbaum; four grandchildren; two sisters 
and a brother. 
If you wish to make a tribute gift in honor 
of any of the above alumni or faculty, 
please contact: Pamela Buell, Washington 
University Medical Alumni and Development, 
Campus Box 1247, 7425 Forsyth Blvd., Suite 2100, 
St. Louis MO 63105-2161, (314) 935-9691.
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The benefits can include:
n Regular income payments for you and/or  
your spouse or another beneficiary for life
n Charitable income tax deductions
n Gift and/or estate tax deductions or reductions
n Reducing, postponing or relieving capital gains tax
Planned giving provides creative 
strategies to support Washington University 
School of Medicine in ways that often are not 
possible through outright gifts. Planned gifts 
also may provide significant financial and tax 
benefits for the donor while ensuring critically 
important programs and projects live on at the 
School of Medicine. Planned gifts can be made 
with cash, appreciated securities or property.  
Types of planned gifts include gifts made by 
will, gift annuities, charitable remainder trusts, 
life insurance and bargain sales.  
You can make a difference!
Pamela Buell, Associate Vice Chancellor for  
Medical Alumni and Development 
(314) 935-9698 or meddev@wustl.edu 
K. Mark Weinrich, Executive Director of  
Planned Giving 
(314) 935-5203 or weinrich@wustl.edu  
Consult with your legal or tax advisor before making a charitable gift.
Poster session in the Farrell Learning and Teaching Center.
PLAN  
 to make an   
 IMPACT
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Fibroblasts (in bright blue), the cells that comprise
many soft tissues throughout the body, grow along
nanofabricated surgical mesh designed in a starburst
pattern. The individual nanofibers originate from a
central point and radiate outward, encouraging cells
to migrate and grow toward the center of a wound.
To learn more about this promising technology,
please turn to page 24.
View enhanced content online:  
outlook.wustl.edu   
Like the School of Medicine on Facebook:  
facebook.com/WUSTLmedicine.health   
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